Foamix Pharma Ord
(FOMX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Sales | 865 | 964 | 906 | 1,043 | 901 |
| Cost of Goods | N/A | N/A | N/A | 2 | 11 |
| Gross Profit | 865 | 964 | 906 | 1,041 | 890 |
| Operating Expenses | 16,451 | 19,751 | 26,626 | 17,666 | 18,729 |
| Operating Income | -15,586 | -18,787 | -25,720 | -16,623 | -17,828 |
| Other Income | 119 | 279 | 73 | 217 | 302 |
| Pre-tax Income | -15,467 | -18,508 | -25,647 | -16,406 | -17,526 |
| Income Tax | 13 | 120 | 330 | 955 | 57 |
| Net Income Continuous | -15,480 | -18,628 | -25,977 | -17,361 | -17,583 |
| Net Income | $-15,480 | $-18,628 | $-25,977 | $-17,361 | $-17,583 |
| EPS Basic Total Ops | -0.38 | -0.46 | -0.69 | -0.46 | -0.47 |
| EPS Basic Continuous Ops | -0.38 | -0.46 | -0.69 | -0.46 | -0.47 |
| EPS Diluted Total Ops | -0.38 | -0.46 | -0.69 | -0.46 | -0.47 |
| EPS Diluted Continuous Ops | -0.38 | -0.46 | -0.69 | -0.46 | -0.47 |
| EPS Diluted Before Non-Recurring Items | -0.38 | -0.46 | -0.69 | N/A | N/A |
| EBITDA(a) | $-15,509 | $-18,707 | $-25,634 | $-16,555 | $-17,766 |